Putting guidelines into everyday practice: co-designing solutions to reduce patient’s risks associated with salbutamol over-prescribing in asthmatic patients aged 12-year-old and over in a general medical practice (ID 769)
Pembroke Medical Group
Abstract
Background
Aligning clinical practice with evidence-based recommendations is slow and complex, often requiring multiple strategies. It can take up to 17 years for research to translate into practice, with implementation rates as low as 8–15%. Ongoing clinical inertia negatively impacts patient outcomes.
An evidence-based emancipatory practice development (EBEPD) framework was implemented to promote ‘embodied integrated knowing’ and empower clinicians to improve asthma management in a practice where salbutamol remained overprescribed two years after NG245 publication. National drivers, including the Greener NHS agenda and the MHRA 2025 Drug Safety Update, reinforced the urgency.
Aims
Reduce risks associated with excessive salbutamol (SABA) prescribing by embedding the NG245 AIR/MART pathway into routine primary care practice
Method
Evidence-based co-design (EBCD) principles and anonymised Microsoft Forms questionnaires were used to:
-Assess clinicians' current perceptions of asthma care quality at the practice
-Explore current clinical practice
-Identify barriers and enablers to NG245 implementation
The World Café model facilitated discussion around workload pressures and implementation challenges.
Results
Around 50% of respondents reported key barriers:
-Limited guideline awareness
-Time constraints
-Lack of confidence
-Established prescribing habits
Confidence gaps were identified:
-5/13 prescribers lacked confidence managing suspected asthma
-6/13 lacked confidence applying updated guidance
Key enablers included:
-EMIS prescribing prompts
-A4 guideline summaries
-Educational sessions
Rapid access to peer support
Conclusion
Improving asthma care requires more than guideline dissemination; it demands culturally embedded, practice-based change. EBEPD and co-design approaches identified key barriers alongside practical, clinician-led solutions, including structured prompts, targeted education, and peer support, which can enable sustained uptake of AIR/MART. Embedding these strategies into routine practice may reduce SABA overuse, enhance patient safety, and align care with local and national guidelines.
Positive deviance, as an asset-based approach, recognises that effective solutions already exist within teams. When combined with EBEPD in time-pressured environments, it enables clinical champions to drive innovation, overcome resistance, and sustain meaningful change.
Funding: None
Conflicts of interest: The author received speaker's fees from AZ, Chiesi for previous events. This project is free from any kind of sponsorship or influence from pharmaceutical industries.
This project is part of MSc Advanced Professional Practice from Plymouth University.